Registration

W STRATEGIES, LLC for CALIFORNIA LIFE SCIENCES

Firm
Client
Income
—
Expenses
—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Copyright/Patent/Trademark CPT

Implementation of PPACA, including provisions related to comparative effectiveness research and a regulatory pathway for biosimilars. Promote life sciences community and communicate economic and health benefits of this industry. Monitor legislation related to Patent Reform. FDA Reform Issues.

LobbyistCovered position, as disclosed
DARREN WILLCOX New Asst for Policy, Speaker Dennis HastertAdmin Asst; Leg Dir; Leg Asst, Cong. Porter GossHouse Rules Comm Assoc, Subcomm Staff Dir.

Health Issues HCR

Implementation of PPACA, including provisions related to comparative effectiveness research and a regulatory pathway for biosimilars. Promote life sciences community and communicate economic and health benefits of this industry. Monitor legislation related to Patent Reform. FDA Reform Issues.

LobbyistCovered position, as disclosed
DARREN WILLCOX New Asst for Policy, Speaker Dennis HastertAdmin Asst; Leg Dir; Leg Asst, Cong. Porter GossHouse Rules Comm Assoc, Subcomm Staff Dir.

Food Industry (safety, labeling, etc.) FOO

Implementation of PPACA, including provisions related to comparative effectiveness research and a regulatory pathway for biosimilars. Promote life sciences community and communicate economic and health benefits of this industry. Monitor legislation related to Patent Reform. FDA Reform Issues.

LobbyistCovered position, as disclosed
DARREN WILLCOX New Asst for Policy, Speaker Dennis HastertAdmin Asst; Leg Dir; Leg Asst, Cong. Porter GossHouse Rules Comm Assoc, Subcomm Staff Dir.

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.